Site activation refers to the process of preparing and authorizing a clinical research site to begin enrolling participants in a study. This crucial step involves completing all necessary regulatory, administrative, and logistical requirements to ensure the site is fully equipped to conduct the trial according to the protocol.
The activation process typically includes tasks such as obtaining institutional review board (IRB) approval, finalizing contracts and budgets, training study staff, and setting up essential equipment and supplies. Once a site is activated, it can officially start screening and enrolling participants, marking the commencement of the active phase of the clinical trial at that location.
Site activation is a critical milestone in clinical research as it directly impacts the timeline and success of a study. Efficient site activation can accelerate participant enrollment, reduce overall study duration, and potentially lead to faster drug or treatment approvals.
Understanding site activation is crucial for sponsors, CROs, and site staff to effectively manage resources and expectations. It helps identify potential bottlenecks in study initiation, allowing for proactive problem-solving and streamlined processes across multiple research sites.
The National Institute of Oncology in Gliwice has launched a pioneering clinical study using a novel radiotracer for immuno-PET imaging.…
The Axcellant team recently returned from Orlando, where we attended the 30th Annual Scientific Session and Exhibition of the American…
A recent publication in npj Digital Medicine explored the use of AI-generated radiology reports — and the results are worth…
Copyright @ 2025 Axcellant